| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.5 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |